Jens Christian R.
- Country
- Sweden
- Department
- Lung-och allergiforskning
Research Overview
- Long-term safety and efficacy of subcutaneous lunsekimig in adults with asthma: An open-label extension study
- Efficacy and Safety of SAR443765 in Adults with High-Risk Asthma Ineligible for Biologic Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of WIN378 (Human IgG1 Monoclonal Antibody Against TSLP) in Adults with Moderate to Severe Asthma
Data & Insights
Has run more than one trial at 53 of 86 partner sites.
Specializations
Respiratory Medicine
This investigator specializes in the treatment of severe asthma, with particular emphasis on patients presenting with an eosinophilic phenotype.
- Inflammatory Airway Disorders
- Eosinophilic Asthma Management
- Biological Therapy Applications
The investigator's work centers on evaluating novel therapeutic approaches for patients with severe respiratory conditions.
Immunology Focus
The investigator concentrates on immunological pathways in respiratory medicine, particularly examining the role of interleukin-5 in asthma treatment.
- Targeted Biological Therapies
- Immune System Modulation
- Anti-inflammatory Treatments
Their research explores innovative therapeutic options for patients with severe inflammatory conditions.
Treatment Innovation
This investigator evaluates novel therapeutic agents for severe asthma, focusing on comparing different treatment approaches for optimal patient outcomes.
- Comparative Treatment Studies
- Long-term Disease Management
- Therapeutic Efficacy Assessment
Their work advances understanding of treatment options for severe respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.